Trimethoprim-d9 |
| Katalog-Nr.GC66422 |
Trimethoprim-d9 ist das als Trimethoprim bezeichnete Deuterium. Trimethoprim ist ein bakteriostatisches Antibiotikum und ein oral wirksamer Dihydrofolat-Reduktase-Hemmer. Trimethoprim ist gegen ein breites Spektrum grampositiver und gramnegativer aerober Bakterien wirksam. Trimethoprim hat das Potenzial zur Behandlung von Harnwegsinfektionen, Shigellose und Pneumocystis-Pneumonie.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1189460-62-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Trimethoprim-d9 is the deuterium labeled Trimethoprim. Trimethoprim is a bacteriostatic antibiotic and an orally active dihydrofolate reductase inhibitor. Trimethoprim is active against a wide range of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim has the potential for urinary tract infections, Shigellosis and Pneumocystis pneumonia treatment[1][2][3].
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *